drug_type
RELEVANT_DRUG
intervention_type
Drug
drug_description
Fc-glycosylated, fully humanized anti-CTLA-4 monoclonal antibody immune checkpoint inhibitor that blocks CTLA-4 to enhance CD28-mediated T-cell priming and may deplete Tregs via ADCC/CDC.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_mesh_term
CTLA-4 Antigen
drug_category
INHIBITORY ANTIBODY
drug_class
Inhibitor
drug_delivery_route
Intravenous
drug_mechanism_of_action
Fully humanized anti-CTLA-4 monoclonal antibody that blocks CTLA-4 interactions to enhance CD28-mediated T-cell priming; Fc glycosylation maintains effector function enabling depletion of intratumoral regulatory T cells via ADCC/CDC.
drug_name
BAT4706
nct_id_drug_ref
NCT06139536